AT008 is a monoclonal antibody that targets GPCR and inhibits the binding of chemokine ligands to their cell surface receptor, CCR4. [AT008] is applicable in the study of certain hematological cancers and solid tumors.
Target:
CCR
* VAT and and shipping costs not included. Errors and price changes excepted
